-
My Account
co-presented by
ASSOCIATE SPONSORS
In App
My Account
co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
BSE Live
Feb 13, 16:01Prev. Close
1003.75
Open Price
993.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 13, 15:47Prev. Close
1002.30
Open Price
1001.00
Bid Price (Qty.)
977.30 (140)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Epigral (in Rs. Cr.) | Mar 20 | Mar 19 | |
| 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 140.99 | 242.29 | |
| Net CashFlow From Operating Activities | 164.68 | 261.35 | |
| Net Cash Used In Investing Activities | -363.21 | -217.30 | |
| Net Cash Used From Financing Activities | 69.41 | 85.09 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -129.12 | 129.14 | |
| Cash And Cash Equivalents Begin of Year | 129.21 | 0.07 | |
| Cash And Cash Equivalents End Of Year | 0.10 | 129.21 |
03.02.2026
Epigral Consolidated December 2025 Net Sales at Rs 597.12 crore, down 7.46% Y-o-Y
03.02.2026
Epigral Standalone December 2025 Net Sales at Rs 597.12 crore, down 7.46% Y-o-Y
30.01.2026
Astral, Epigral to gain from China’s VAT rebate rollback on PVC
14.11.2025
Epigral Consolidated September 2025 Net Sales at Rs 587.36 crore, down 6.18% Y-o-Y
03.02.2026
Epigral Consolidated December 2025 Net Sales at Rs 597.12 crore, down 7.46% Y-o-Y
03.02.2026
Epigral Standalone December 2025 Net Sales at Rs 597.12 crore, down 7.46% Y-o-Y
14.11.2025
Epigral Consolidated September 2025 Net Sales at Rs 587.36 crore, down 6.18% Y-o-Y
11.11.2025
Epigral Standalone September 2025 Net Sales at Rs 587.36 crore, down 6.18% Y-o-Y
